SCHEMBL2705971

SCHEMBL2705971

C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3CC[C@@](O)(C(=O)O)[C@@]3(C)C[C@H](O)C12F

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 9/20 0.74
CYP3A4 P08684 9/20 0.74
LMNA P02545 5/20 0.74
ALDH1A1 P00352 1/20 0.74
NR3C1 P04150 7/20 0.69
HSD17B10 Q99714 4/20 0.63
PGR P06401 4/20 0.63
CYP2C9 P11712 4/20 0.63
NFKB1 P19838 3/20 0.63
PMP22 Q01453 2/20 0.63
CYP2J2 P51589 1/20 0.63
BLM P54132 1/20 0.63
CYP2C19 P33261 1/20 0.63
TSHR P16473 2/20 0.61
AR P10275 2/20 0.61
MEN1 O00255 1/20 0.61
CYP2D6 P10635 1/20 0.61
KMT2A Q03164 1/20 0.61
APEX1 P27695 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1627541 1.00 HIF1A (0.74) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL27869024 1.00 HIF1A (0.74) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL11818550 0.92 HIF1A (0.71) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL11818537 0.92 HIF1A (0.71) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL3393688 0.92 HIF1A (0.77) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL10788664 0.92 HIF1A (0.71) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL3393684 0.92 HIF1A (0.77) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL10788659 0.91 HIF1A (0.73) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL3764416 0.89 HIF1A (0.79) HIF1ACYP3A4LMNAALDH1A1NR3C1
SCHEMBL17884670 0.89 HIF1A (0.79) HIF1ACYP3A4LMNAALDH1A1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2435462-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS Pfizer Limited (GB) 2012-04-04 EP disclosed
WO-2010136940-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS PFIZER LIMITED (GB) 2010-12-02 WO disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists NR3C1, NR3C2, MC2R HIF1A 1893/4885CYP3A4 678/4885LMNA 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.